| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.04 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.072 | 0.04 |